Homma C, Kaneko Y, Sekine K, Hara S, Hata J, Sakurai M
Department of Cancer Chemotherapy, Saitama Cancer Center Hospital.
Jpn J Cancer Res. 1989 Sep;80(9):861-5. doi: 10.1111/j.1349-7006.1989.tb01727.x.
A cell line designated SCCH-196 was established from an extraskeletal small round cell sarcoma developed in a 16-year-old Japanese girl. The cells grew as a monolayer, and have been continuously propagated by serial subcultures during the past 26 months. Cells from the primary tumor and those from the SCCH-196 cell line at passage 10 both showed the same karyotype, 51,XX, +8, +20, +21, t(11;22)(q24;q12), +i(1q), +i(1q). Histologically the primary tumor was difficult to classify as either Ewing's sarcoma (ES) or peripheral neuroepithelioma (NE). Neuron-specific enolase-positive cells in the primary tumor and the occurrence in the upper extremity were in favor of NE, while positive reaction of SCCH-196 cells to an ES-specific monoclonal antibody 5C11 suggested a diagnosis of ES. The SCCH-196 cell line may be useful for basic studies on differentiation of neuroectodermal tumors, and for future cloning of still unidentified genes which may be located at the breakpoints of the 11;22 translocation.
一个名为SCCH - 196的细胞系源自一名16岁日本女孩所患的骨外小圆形细胞肉瘤。这些细胞呈单层生长,在过去26个月里通过连续传代培养得以持续增殖。原发肿瘤细胞和第10代SCCH - 196细胞系的细胞均显示相同的核型:51,XX, +8, +20, +21, t(11;22)(q24;q12), +i(1q), +i(1q)。从组织学上看,原发肿瘤难以归类为尤因肉瘤(ES)或外周神经上皮瘤(NE)。原发肿瘤中神经元特异性烯醇化酶阳性细胞以及肿瘤发生在上肢提示为NE,而SCCH - 196细胞对ES特异性单克隆抗体5C11呈阳性反应则提示诊断为ES。SCCH - 196细胞系可能有助于神经外胚层肿瘤分化的基础研究,以及未来对可能位于11;22易位断点处的尚未鉴定基因的克隆。